Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 133Brain Neoplasms 129Prostatic Neoplasms 108Neoplasm Metastasis 88Lung Neoplasms 74Carcinoma, Hepatocellular 71Pancreatic Neoplasms 69Breast Neoplasms 50Melanoma 44Carcinoma, Renal Cell 36Neoplasms 34Colorectal Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Glioblastoma 24Liver Neoplasms 20Head and Neck Neoplasms 17Small Cell Lung Carcinoma 15Sarcoma 13Kidney Neoplasms 13Glioma 12Urinary Bladder Neoplasms 10Recurrence 9Gliosarcoma 8Ovarian Neoplasms 7Central Nervous System Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma 7Radiation Injuries 6Prostate Cancer Metastatic 6Neuroma, Acoustic 6

Interventions

lorlatinib 3pembrolizumab 2osimertinib 2Radiotherapy 2atezolizumab 1Temozolomide 1Radiosurgery 1Paclitaxel 1Nivolumab 1Ipilimumab 1Fecal Microbiota Transplantation 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non Small Cell Lung Cancer Metastatic × Radiosurgery × Clear all
NCT06741085 2026-04-13

A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
56 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡